A further study showed that this effect was due to excessive immunosuppression, as the treatment on ALS mice lacking mature lymphocytes increased ALS survival.[23] However, being the evidences on Rapamycin action mainly on models linked to TDP43 pathology, we will exclude patients carrying SOD1 mutations. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.